CBD Life Sciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBDL research report →
Companylbcbioscienceinc.com
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products.
- CEO
- Lisa Anne Nelson
- IPO
- 2009
- Employees
- 3
- HQ
- Scottsdale, AZ, US
Price Chart
Valuation
- Market Cap
- $478.63K
- P/E
- -174.18
- P/S
- 10.82
- P/B
- 1.37
- EV/EBITDA
- -3.21
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -1.61%
- Op Margin
- -145.54%
- Net Margin
- -13.60%
- ROE
- -1.00%
- ROIC
- -8.40%
Growth & Income
- Revenue
- $98.32K · -9.71%
- Net Income
- $-48,929 · 93.54%
- EPS
- $0.00 · 100.00%
- Op Income
- $-101,702
- FCF YoY
- 76.14%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -3603.52
- Avg Volume
- 25.11M
Get TickerSpark's AI analysis on CBDL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CBDL Coverage
We haven't published any research on CBDL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CBDL Report →